Premium
Extracellular vesicles and their non‐coding RNA cargos: Emerging players in cardiovascular disease
Author(s) -
Collado Aida,
Gan Lu,
Tengbom John,
Kontidou Eftychia,
Pernow John,
Zhou Zhichao
Publication year - 2022
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jp283200
Subject(s) - microvesicles , disease , immune system , cell type , microrna , non coding rna , biology , extracellular vesicle , extracellular vesicles , stem cell , microbiology and biotechnology , bioinformatics , cell , immunology , medicine , pathology , gene , genetics
Extracellular vesicles (EVs), including exosomes, microvesicles and apoptotic bodies, have recently received attention as essential mechanisms for cell‐to‐cell communication in cardiovascular disease. EVs can be released from different types of cells, including endothelial cells, smooth muscle cells, cardiac cells, fibroblasts, platelets, adipocytes, immune cells and stem cells. Non‐coding (nc)RNAs as EV cargos have recently been investigated in the cardiovascular system. Up‐ or downregulated ncRNAs in EVs have been shown to play a crucial role in various cardiovascular diseases. Communication via EV‐derived ncRNAs can occur between cells of the same type and between different types of cells involved in the pathophysiology of cardiovascular disease. In the present review, we highlight the important aspects of diverse cell‐derived EVs and their ncRNA cargos as disease mediators and potential therapeutic targets in atherosclerosis, coronary artery disease, ischaemic heart disease and cardiac fibrosis. In addition, we summarize the potential of EV‐derived ncRNAs in the treatment of cardiovascular disease. Finally, we discuss the different methods for EV isolation and characterization. A better understanding of the specific role of EVs and their ncRNA cargos in the regulation of cardiovascular (dys)function will be of importance for the development of diagnostic and therapeutic tools for cardiovascular disease.